Financials & Filings Fourth Quarter 2017 Financial Results Show all 2017 Q4 Karyopharm Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Progress Karyopharm Therapeutics 4Q 2017 Earnings Call Form 10-K Proxy Statements Filing date View Apr 28, 2014 0001047469-14-004227.pdf 0001047469-14-004227.rtf 0001047469-14-004227.xls View HTML Apr 7, 2015 0001193125-15-121353.pdf 0001193125-15-121353.rtf 0001193125-15-121353.xls View HTML Form 10-K Filing date View Mar 21, 2014 View HTML 0001047469-14-002800.pdf 0001047469-14-002800.rtf 0001047469-14-002800.xls EX-101.INS - EX-101.INS Mar 13, 2015 View HTML 0001193125-15-091264.pdf 0001193125-15-091264.rtf 0001193125-15-091264.xls EX-101.INS - XBRL INSTANCE DOCUMENT Form 10-Q Filing date View Dec 20, 2013 0001104659-13-091618.pdf 0001104659-13-091618.rtf 0001104659-13-091618.xls View HTML Dec 23, 2013 0001104659-13-091964.pdf 0001104659-13-091964.rtf 0001104659-13-091964.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Financials & Filings Fourth Quarter 2017 Financial Results Show all 2017 Q4 Karyopharm Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Progress Karyopharm Therapeutics 4Q 2017 Earnings Call Form 10-K Proxy Statements Filing date View Apr 28, 2014 0001047469-14-004227.pdf 0001047469-14-004227.rtf 0001047469-14-004227.xls View HTML Apr 7, 2015 0001193125-15-121353.pdf 0001193125-15-121353.rtf 0001193125-15-121353.xls View HTML Form 10-K Filing date View Mar 21, 2014 View HTML 0001047469-14-002800.pdf 0001047469-14-002800.rtf 0001047469-14-002800.xls EX-101.INS - EX-101.INS Mar 13, 2015 View HTML 0001193125-15-091264.pdf 0001193125-15-091264.rtf 0001193125-15-091264.xls EX-101.INS - XBRL INSTANCE DOCUMENT Form 10-Q Filing date View Dec 20, 2013 0001104659-13-091618.pdf 0001104659-13-091618.rtf 0001104659-13-091618.xls View HTML Dec 23, 2013 0001104659-13-091964.pdf 0001104659-13-091964.rtf 0001104659-13-091964.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML